Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. August 2017 03:05 ET | Quelle: PreveCeutical Medical Inc

PreveCeutical™ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics

VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces that on August 7, 2017, the Company signed...
17. Juli 2017 08:30 ET | Quelle: PreveCeutical Medical Inc

PreveCeutical signs Research and Option Agreement with UniQuest Pty Limited for Developing Dual-Gene Therapy Treatment for Diabetes and Obesity

VANCOUVER, British Columbia, July 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces, further to its news release dated April 13, 2017,...
24. April 2017 08:30 ET | Quelle: PreveCeutical Medical Inc

PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels

VANCOUVER, British Columbia, April 24, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilising nature and science for the benefit of...